"10.1371_journal.pone.0144746","plos one","2015-12-29T00:00:00Z","Valérie Potard; Jacques Reynes; Tristan Ferry; Céline Aubin; Laurent Finkielsztejn; Yazdan Yazdanpanah; Dominique Costagliola; FHDH ANRS CO4","Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Paris, France; INSERM, UMR_S 1136, Institut Pierre Louis dEpidémiologie et de Santé Publique, Paris, France; Inserm Transfert, Paris, France; Université Montpellier, Montpellier, France; IRD, UMI233 TransVIHMI Montpellier, France; Département de Maladies Infectieuses et Tropicales, CHU Montpellier, France; Services de Maladies Infectieuses et Tropicales, Hospices Civils de Lyon; Université Claude Bernard Lyon1; CIRI, International Center for Infectiology Research, INSERM U1111, Lyon, France; Laboratoire GSK, Marly-Le-Roi, France; Laboratoire ViiVHealthcare, Marly-Le-Roi, France; Université Paris Diderot 7, Paris, France; INSERM, UMR_S 1137, ATIP-Avenir Inserm: Modélisation, Aide à la Décision, et Coût-Efficacité en Maladies Infectieuses, Paris, France; Service des Maladies Infectieuses et Tropicales, Hôpital Bichat, France","Conceived and designed the experiments: VP DC. Analyzed the data: VP. Contributed reagents/materials/analysis tools: VP DC JR YY TF. Wrote the paper: VP JR TF CA LF YY DC. Proposed the study: LF DC. Included patients: JR YY TF.","The study was sponsored by Viiv Healthcare. The author LF is affiliated with ViiV as the funding organization and have had a role in the study design, preparation of the manuscript and decision to publish. The author CA is affiliated with GSK and have had a role in the study design, preparation of the manuscript and decision to publish. Furthermore, CA and LF have an affiliation to the commercial funders of this research study ViiV. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","12","Valérie Potard","VP",8,TRUE,2,NA,1,7,TRUE,TRUE,FALSE,0,NA,FALSE
